• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BOT 3.21% 40.3¢

BOTANIX PHARMACEUTICALS LTD - Announcements

Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix... Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix (USA), committed to the development of novel treatments for common skin diseases and infections.More

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

Filters [Clear]
  • Price Sensitive: Yes
BOT Botanix Appendix 4E & Announcement of Commercial Day WebinarPRICE SENSITIVE30/08/24 download Created with Sketch. 890.05KB
BOT June 2024 Quarterly Activities Report and Appendix 4CPRICE SENSITIVE31/07/24 download Created with Sketch. 1.09MB
BOT Botanix $70 Million Institutional Capital RaisingPRICE SENSITIVE21/06/24 download Created with Sketch. 9.55MB
BOT FDA Approves SofdraPRICE SENSITIVE20/06/24 download Created with Sketch. 294.08KB
BOT Trading HaltPRICE SENSITIVE19/06/24 download Created with Sketch. 541.96KB
BOT Final Sofdra Labelling Discussions with FDAPRICE SENSITIVE12/06/24 download Created with Sketch. 190.63KB
BOT March 2024 Quarterly Activities Report and Appendix 4CPRICE SENSITIVE30/04/24 download Created with Sketch. 1.04MB
BOT S&P DJI Announces March 2024 Quarterly RebalancePRICE SENSITIVE01/03/24 download Created with Sketch. 120.24KB
BOT Botanix Pharmaceuticals Half Year ReportPRICE SENSITIVE28/02/24 download Created with Sketch. 174.22KB
BOT Appendix 4D and Half Year ReportPRICE SENSITIVE28/02/24 download Created with Sketch. 845.87KB
BOT December 2023 Quarterly Activities Report and Appendix 4CPRICE SENSITIVE31/01/24 download Created with Sketch. 1.04MB
BOT NDA Resubmission Accepted and Approval Date ConfirmedPRICE SENSITIVE22/01/24 download Created with Sketch. 174.86KB
BOT Botanix Resubmission of NDA for Sofdra CompletedPRICE SENSITIVE21/12/23 download Created with Sketch. 203.19KB
BOT Successful Completion of Human Factors StudyPRICE SENSITIVE14/12/23 download Created with Sketch. 205.97KB
BOT FDA Confirms Approach to Sofdra NDA ResubmissionPRICE SENSITIVE04/12/23 download Created with Sketch. 199.63KB
BOT Successful Completion of $13.5m Institutional PlacementPRICE SENSITIVE01/12/23 download Created with Sketch. 197.78KB
BOT Botanix Placement Secures $13.5M to Fund Sofdra Launch PrepPRICE SENSITIVE27/11/23 download Created with Sketch. 233.7KB
BOT Trading HaltPRICE SENSITIVE23/11/23 download Created with Sketch. 536.83KB
BOT Investor Presentation and Investor MeetingsPRICE SENSITIVE31/10/23 download Created with Sketch. 2.65MB
BOT September 2023 Quarterly Activities Report and Appendix 4CPRICE SENSITIVE31/10/23 download Created with Sketch. 652.53KB
BOT Presentation- FDA Letter Requires Patient Instruction UpdatePRICE SENSITIVE26/09/23 download Created with Sketch. 857.14KB
BOT FDA Letter Requires Patient Instruction UpdatePRICE SENSITIVE26/09/23 download Created with Sketch. 382.54KB
BOT Trading HaltPRICE SENSITIVE25/09/23 download Created with Sketch. 542.03KB
BOT Response to ASX Price and Volume QueryPRICE SENSITIVE20/09/23 download Created with Sketch. 765.98KB
BOT Appendix 4E Preliminary Final ReportPRICE SENSITIVE31/08/23 download Created with Sketch. 482.48KB
BOT Appointment of Dr Howie McKibbon as CEOPRICE SENSITIVE25/08/23 download Created with Sketch. 260.88KB
BOT June 2023 Quarterly Activities Report and Appendix 4CPRICE SENSITIVE31/07/23 download Created with Sketch. 583.44KB
BOT Botanix Closes Capital Raising and Royalty Milestone BuyoutPRICE SENSITIVE27/07/23 download Created with Sketch. 192.7KB
BOT Botanix Capital Raising to Extinguish Milestone & RoyaltyPRICE SENSITIVE21/07/23 download Created with Sketch. 924.83KB
BOT Trading HaltPRICE SENSITIVE19/07/23 download Created with Sketch. 210.72KB
BOT New Territory Licensed for Sofpironium Bromide with KakenPRICE SENSITIVE05/06/23 download Created with Sketch. 230.77KB
BOT Pause in tradingPRICE SENSITIVE05/06/23 download Created with Sketch. 116.5KB
BOT March 2023 Quarterly Activities Report and Appendix 4CPRICE SENSITIVE28/04/23 download Created with Sketch. 359.56KB
BOT Botanix successfully completes A$10m PlacementPRICE SENSITIVE13/04/23 download Created with Sketch. 227.27KB
BOT Botanix Raises A$10 million via Institutional PlacementPRICE SENSITIVE05/04/23 download Created with Sketch. 239.06KB
BOT Trading HaltPRICE SENSITIVE03/04/23 download Created with Sketch. 542.36KB
BOT FDA Mid-Cycle Review Meeting Successfully CompletedPRICE SENSITIVE03/04/23 download Created with Sketch. 161.7KB
BOT Response to ASX Price and Volume QueryPRICE SENSITIVE10/03/23 download Created with Sketch. 710.25KB
BOT Half Yearly Report and AccountsPRICE SENSITIVE28/02/23 download Created with Sketch. 626.69KB
BOT Press Article CorrectionPRICE SENSITIVE15/02/23 download Created with Sketch. 174.44KB
BOT Trading HaltPRICE SENSITIVE14/02/23 download Created with Sketch. 155.41KB
BOT Pause in TradingPRICE SENSITIVE14/02/23 download Created with Sketch. 118.23KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE31/01/23 download Created with Sketch. 349KB
BOT Confirmation Sofpironium Bromide NDA Formally Under ReviewPRICE SENSITIVE08/12/22 download Created with Sketch. 245.36KB
BOT Placement Completion and Results of Share Purchase PlanPRICE SENSITIVE29/11/22 download Created with Sketch. 231.93KB
BOT Share Purchase Plan OpensPRICE SENSITIVE09/11/22 download Created with Sketch. 663.09KB
BOT A$5 million Institutional Placement and Share Purchase PlanPRICE SENSITIVE31/10/22 download Created with Sketch. 271.47KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE27/10/22 download Created with Sketch. 344.25KB
BOT Trading HaltPRICE SENSITIVE27/10/22 download Created with Sketch. 539.21KB
BOT Botanix receives A$3.7m R&D Tax Incentive RefundPRICE SENSITIVE26/10/22 download Created with Sketch. 205.91KB
BOT BOT Announces Promotion and Focus on NDA Approval ReadinessPRICE SENSITIVE21/10/22 download Created with Sketch. 235.84KB
BOT Positive BTX 1702 Phase 1b/2 Clinical Study for RosaceaPRICE SENSITIVE13/10/22 download Created with Sketch. 5.36MB
BOT Trading HaltPRICE SENSITIVE12/10/22 download Created with Sketch. 539.2KB
BOT BOT Submits FDA New Drug Application for Sofpironium BromidePRICE SENSITIVE26/09/22 download Created with Sketch. 242.69KB
BOT Issue of First $7.0m Tranche of A$7.5m Placement CompletedPRICE SENSITIVE12/09/22 download Created with Sketch. 240.36KB
BOT Botanix Completes Successful A$7.5m PlacementPRICE SENSITIVE02/09/22 download Created with Sketch. 295.63KB
BOT Trading HaltPRICE SENSITIVE31/08/22 download Created with Sketch. 171.59KB
BOT Preliminary Final ReportPRICE SENSITIVE31/08/22 download Created with Sketch. 328.2KB
BOT Quarterly activities report and Appendix 4CPRICE SENSITIVE29/07/22 download Created with Sketch. 399.13KB
BOT NDA Filing Accelerated and Trials Fully EnrolledPRICE SENSITIVE07/07/22 download Created with Sketch. 216.21KB
BOT Dermatology Asset Acquired to Accelerate Path to RevenuePRICE SENSITIVE04/05/22 download Created with Sketch. 11.93MB
BOT Trading HaltPRICE SENSITIVE03/05/22 download Created with Sketch. 170.93KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE29/04/22 download Created with Sketch. 357.73KB
BOT FDA Qualified Infectious Disease Product Status for BTX 1801PRICE SENSITIVE28/04/22 download Created with Sketch. 238.83KB
BOT Half Yearly Report and AccountsPRICE SENSITIVE22/02/22 download Created with Sketch. 764.45KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE28/01/22 download Created with Sketch. 352.87KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE25/10/21 download Created with Sketch. 360.92KB
BOT Canine Atopic Dermatitis Program LaunchedPRICE SENSITIVE29/09/21 download Created with Sketch. 202.24KB
BOT Final Report and Annual Report to ShareholdersPRICE SENSITIVE27/08/21 download Created with Sketch. 1.27MB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE23/07/21 download Created with Sketch. 426.55KB
BOT New Canine Pilot Study Supports Further AD InvestigationPRICE SENSITIVE17/05/21 download Created with Sketch. 825.94KB
BOT Botanix Update on BTX 1801 Clinical DevelopmentPRICE SENSITIVE04/05/21 download Created with Sketch. 4.66MB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE30/04/21 download Created with Sketch. 377.91KB
BOT BTX 1702 Rosacea Study ApprovalPRICE SENSITIVE30/03/21 download Created with Sketch. 200.44KB
BOT Half Yearly Report and AccountsPRICE SENSITIVE26/02/21 download Created with Sketch. 730.63KB
BOT Botanix receives A$6.87m R&D Tax Incentive RefundPRICE SENSITIVE12/02/21 download Created with Sketch. 191.46KB
BOT Phase 2a Study Shows BTX 1801 Eradicates S. AureusPRICE SENSITIVE03/02/21 download Created with Sketch. 233.38KB
BOT Trading HaltPRICE SENSITIVE01/02/21 download Created with Sketch. 556.72KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE22/01/21 download Created with Sketch. 319.75KB
BOT Antimicrobial Data Published in Peer-Reviewed JournalPRICE SENSITIVE20/01/21 download Created with Sketch. 389.41KB
BOT Update on BTX 1801 Phase 2a Clinical StudyPRICE SENSITIVE14/12/20 download Created with Sketch. 170.19KB
BOT FDA Clears Development Path for BTX 1801PRICE SENSITIVE11/11/20 download Created with Sketch. 192.92KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE13/10/20 download Created with Sketch. 355.44KB
BOT Response to ASX Price QueryPRICE SENSITIVE29/09/20 download Created with Sketch. 708.96KB
BOT New Antimicrobial Data and Conference PresentationPRICE SENSITIVE08/09/20 download Created with Sketch. 1.73MB
BOT Appendix 4E and Annual Report to ShareholdersPRICE SENSITIVE31/08/20 download Created with Sketch. 1.01MB
BOT BTX 1801 Phase 2a Antimicrobial Study UnderwayPRICE SENSITIVE12/08/20 download Created with Sketch. 187.59KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE30/07/20 download Created with Sketch. 326.32KB
BOT Response to ASX Aware QueryPRICE SENSITIVE22/07/20 download Created with Sketch. 740.97KB
BOT BTX 1503 End of Phase 2 Milestone with FDAPRICE SENSITIVE17/07/20 download Created with Sketch. 160.69KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE30/04/20 download Created with Sketch. 303.6KB
BOT FDA Grants BTX 1801 QIDP Designation StatusPRICE SENSITIVE24/04/20 download Created with Sketch. 275.59KB
BOT Botanix Provides Update on Development Activities AmendedPRICE SENSITIVE16/04/20 download Created with Sketch. 300.12KB
BOT Botanix Provides Update on Development ActivitiesPRICE SENSITIVE16/04/20 download Created with Sketch. 243.29KB
BOT Botanix Announces Top Line BTX 1204 Atopic Dermatitis DataPRICE SENSITIVE25/03/20 download Created with Sketch. 218.13KB
BOT Trading HaltPRICE SENSITIVE24/03/20 download Created with Sketch. 215.48KB
BOT Antimicrobial Platform Update and Launch of BTX 1801 StudyPRICE SENSITIVE13/03/20 download Created with Sketch. 5.77MB
BOT Half Yearly Report and AccountsPRICE SENSITIVE28/02/20 download Created with Sketch. 925.03KB
BOT Appendix 4C - QuarterlyPRICE SENSITIVE31/01/20 download Created with Sketch. 380KB
BOT Botanix Initiates BTX 1702 Rosacea StudyPRICE SENSITIVE09/12/19 download Created with Sketch. 160.86KB
BOT Botanix Appendix 4E & Announcement of Commercial Day Webinar
30/08/24PRICE SENSITIVE download Created with Sketch. 890.05KB
BOT June 2024 Quarterly Activities Report and Appendix 4C
31/07/24PRICE SENSITIVE download Created with Sketch. 1.09MB
BOT Botanix $70 Million Institutional Capital Raising
21/06/24PRICE SENSITIVE download Created with Sketch. 9.55MB
BOT FDA Approves Sofdra
20/06/24PRICE SENSITIVE download Created with Sketch. 294.08KB
BOT Trading Halt
19/06/24PRICE SENSITIVE download Created with Sketch. 541.96KB
BOT Final Sofdra Labelling Discussions with FDA
12/06/24PRICE SENSITIVE download Created with Sketch. 190.63KB
BOT March 2024 Quarterly Activities Report and Appendix 4C
30/04/24PRICE SENSITIVE download Created with Sketch. 1.04MB
BOT S&P DJI Announces March 2024 Quarterly Rebalance
01/03/24PRICE SENSITIVE download Created with Sketch. 120.24KB
BOT Botanix Pharmaceuticals Half Year Report
28/02/24PRICE SENSITIVE download Created with Sketch. 174.22KB
BOT Appendix 4D and Half Year Report
28/02/24PRICE SENSITIVE download Created with Sketch. 845.87KB
BOT December 2023 Quarterly Activities Report and Appendix 4C
31/01/24PRICE SENSITIVE download Created with Sketch. 1.04MB
BOT NDA Resubmission Accepted and Approval Date Confirmed
22/01/24PRICE SENSITIVE download Created with Sketch. 174.86KB
BOT Botanix Resubmission of NDA for Sofdra Completed
21/12/23PRICE SENSITIVE download Created with Sketch. 203.19KB
BOT Successful Completion of Human Factors Study
14/12/23PRICE SENSITIVE download Created with Sketch. 205.97KB
BOT FDA Confirms Approach to Sofdra NDA Resubmission
04/12/23PRICE SENSITIVE download Created with Sketch. 199.63KB
BOT Successful Completion of $13.5m Institutional Placement
01/12/23PRICE SENSITIVE download Created with Sketch. 197.78KB
BOT Botanix Placement Secures $13.5M to Fund Sofdra Launch Prep
27/11/23PRICE SENSITIVE download Created with Sketch. 233.7KB
BOT Trading Halt
23/11/23PRICE SENSITIVE download Created with Sketch. 536.83KB
BOT Investor Presentation and Investor Meetings
31/10/23PRICE SENSITIVE download Created with Sketch. 2.65MB
BOT September 2023 Quarterly Activities Report and Appendix 4C
31/10/23PRICE SENSITIVE download Created with Sketch. 652.53KB
BOT Presentation- FDA Letter Requires Patient Instruction Update
26/09/23PRICE SENSITIVE download Created with Sketch. 857.14KB
BOT FDA Letter Requires Patient Instruction Update
26/09/23PRICE SENSITIVE download Created with Sketch. 382.54KB
BOT Trading Halt
25/09/23PRICE SENSITIVE download Created with Sketch. 542.03KB
BOT Response to ASX Price and Volume Query
20/09/23PRICE SENSITIVE download Created with Sketch. 765.98KB
BOT Appendix 4E Preliminary Final Report
31/08/23PRICE SENSITIVE download Created with Sketch. 482.48KB
BOT Appointment of Dr Howie McKibbon as CEO
25/08/23PRICE SENSITIVE download Created with Sketch. 260.88KB
BOT June 2023 Quarterly Activities Report and Appendix 4C
31/07/23PRICE SENSITIVE download Created with Sketch. 583.44KB
BOT Botanix Closes Capital Raising and Royalty Milestone Buyout
27/07/23PRICE SENSITIVE download Created with Sketch. 192.7KB
BOT Botanix Capital Raising to Extinguish Milestone & Royalty
21/07/23PRICE SENSITIVE download Created with Sketch. 924.83KB
BOT Trading Halt
19/07/23PRICE SENSITIVE download Created with Sketch. 210.72KB
BOT New Territory Licensed for Sofpironium Bromide with Kaken
05/06/23PRICE SENSITIVE download Created with Sketch. 230.77KB
BOT Pause in trading
05/06/23PRICE SENSITIVE download Created with Sketch. 116.5KB
BOT March 2023 Quarterly Activities Report and Appendix 4C
28/04/23PRICE SENSITIVE download Created with Sketch. 359.56KB
BOT Botanix successfully completes A$10m Placement
13/04/23PRICE SENSITIVE download Created with Sketch. 227.27KB
BOT Botanix Raises A$10 million via Institutional Placement
05/04/23PRICE SENSITIVE download Created with Sketch. 239.06KB
BOT Trading Halt
03/04/23PRICE SENSITIVE download Created with Sketch. 542.36KB
BOT FDA Mid-Cycle Review Meeting Successfully Completed
03/04/23PRICE SENSITIVE download Created with Sketch. 161.7KB
BOT Response to ASX Price and Volume Query
10/03/23PRICE SENSITIVE download Created with Sketch. 710.25KB
BOT Half Yearly Report and Accounts
28/02/23PRICE SENSITIVE download Created with Sketch. 626.69KB
BOT Press Article Correction
15/02/23PRICE SENSITIVE download Created with Sketch. 174.44KB
BOT Trading Halt
14/02/23PRICE SENSITIVE download Created with Sketch. 155.41KB
BOT Pause in Trading
14/02/23PRICE SENSITIVE download Created with Sketch. 118.23KB
BOT Appendix 4C - Quarterly
31/01/23PRICE SENSITIVE download Created with Sketch. 349KB
BOT Confirmation Sofpironium Bromide NDA Formally Under Review
08/12/22PRICE SENSITIVE download Created with Sketch. 245.36KB
BOT Placement Completion and Results of Share Purchase Plan
29/11/22PRICE SENSITIVE download Created with Sketch. 231.93KB
BOT Share Purchase Plan Opens
09/11/22PRICE SENSITIVE download Created with Sketch. 663.09KB
BOT A$5 million Institutional Placement and Share Purchase Plan
31/10/22PRICE SENSITIVE download Created with Sketch. 271.47KB
BOT Appendix 4C - Quarterly
27/10/22PRICE SENSITIVE download Created with Sketch. 344.25KB
BOT Trading Halt
27/10/22PRICE SENSITIVE download Created with Sketch. 539.21KB
BOT Botanix receives A$3.7m R&D Tax Incentive Refund
26/10/22PRICE SENSITIVE download Created with Sketch. 205.91KB
BOT BOT Announces Promotion and Focus on NDA Approval Readiness
21/10/22PRICE SENSITIVE download Created with Sketch. 235.84KB
BOT Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea
13/10/22PRICE SENSITIVE download Created with Sketch. 5.36MB
BOT Trading Halt
12/10/22PRICE SENSITIVE download Created with Sketch. 539.2KB
BOT BOT Submits FDA New Drug Application for Sofpironium Bromide
26/09/22PRICE SENSITIVE download Created with Sketch. 242.69KB
BOT Issue of First $7.0m Tranche of A$7.5m Placement Completed
12/09/22PRICE SENSITIVE download Created with Sketch. 240.36KB
BOT Botanix Completes Successful A$7.5m Placement
02/09/22PRICE SENSITIVE download Created with Sketch. 295.63KB
BOT Trading Halt
31/08/22PRICE SENSITIVE download Created with Sketch. 171.59KB
BOT Preliminary Final Report
31/08/22PRICE SENSITIVE download Created with Sketch. 328.2KB
BOT Quarterly activities report and Appendix 4C
29/07/22PRICE SENSITIVE download Created with Sketch. 399.13KB
BOT NDA Filing Accelerated and Trials Fully Enrolled
07/07/22PRICE SENSITIVE download Created with Sketch. 216.21KB
BOT Dermatology Asset Acquired to Accelerate Path to Revenue
04/05/22PRICE SENSITIVE download Created with Sketch. 11.93MB
BOT Trading Halt
03/05/22PRICE SENSITIVE download Created with Sketch. 170.93KB
BOT Appendix 4C - Quarterly
29/04/22PRICE SENSITIVE download Created with Sketch. 357.73KB
BOT FDA Qualified Infectious Disease Product Status for BTX 1801
28/04/22PRICE SENSITIVE download Created with Sketch. 238.83KB
BOT Half Yearly Report and Accounts
22/02/22PRICE SENSITIVE download Created with Sketch. 764.45KB
BOT Appendix 4C - Quarterly
28/01/22PRICE SENSITIVE download Created with Sketch. 352.87KB
BOT Appendix 4C - Quarterly
25/10/21PRICE SENSITIVE download Created with Sketch. 360.92KB
BOT Canine Atopic Dermatitis Program Launched
29/09/21PRICE SENSITIVE download Created with Sketch. 202.24KB
BOT Final Report and Annual Report to Shareholders
27/08/21PRICE SENSITIVE download Created with Sketch. 1.27MB
BOT Appendix 4C - Quarterly
23/07/21PRICE SENSITIVE download Created with Sketch. 426.55KB
BOT New Canine Pilot Study Supports Further AD Investigation
17/05/21PRICE SENSITIVE download Created with Sketch. 825.94KB
BOT Botanix Update on BTX 1801 Clinical Development
04/05/21PRICE SENSITIVE download Created with Sketch. 4.66MB
BOT Appendix 4C - Quarterly
30/04/21PRICE SENSITIVE download Created with Sketch. 377.91KB
BOT BTX 1702 Rosacea Study Approval
30/03/21PRICE SENSITIVE download Created with Sketch. 200.44KB
BOT Half Yearly Report and Accounts
26/02/21PRICE SENSITIVE download Created with Sketch. 730.63KB
BOT Botanix receives A$6.87m R&D Tax Incentive Refund
12/02/21PRICE SENSITIVE download Created with Sketch. 191.46KB
BOT Phase 2a Study Shows BTX 1801 Eradicates S. Aureus
03/02/21PRICE SENSITIVE download Created with Sketch. 233.38KB
BOT Trading Halt
01/02/21PRICE SENSITIVE download Created with Sketch. 556.72KB
BOT Appendix 4C - Quarterly
22/01/21PRICE SENSITIVE download Created with Sketch. 319.75KB
BOT Antimicrobial Data Published in Peer-Reviewed Journal
20/01/21PRICE SENSITIVE download Created with Sketch. 389.41KB
BOT Update on BTX 1801 Phase 2a Clinical Study
14/12/20PRICE SENSITIVE download Created with Sketch. 170.19KB
BOT FDA Clears Development Path for BTX 1801
11/11/20PRICE SENSITIVE download Created with Sketch. 192.92KB
BOT Appendix 4C - Quarterly
13/10/20PRICE SENSITIVE download Created with Sketch. 355.44KB
BOT Response to ASX Price Query
29/09/20PRICE SENSITIVE download Created with Sketch. 708.96KB
BOT New Antimicrobial Data and Conference Presentation
08/09/20PRICE SENSITIVE download Created with Sketch. 1.73MB
BOT Appendix 4E and Annual Report to Shareholders
31/08/20PRICE SENSITIVE download Created with Sketch. 1.01MB
BOT BTX 1801 Phase 2a Antimicrobial Study Underway
12/08/20PRICE SENSITIVE download Created with Sketch. 187.59KB
BOT Appendix 4C - Quarterly
30/07/20PRICE SENSITIVE download Created with Sketch. 326.32KB
BOT Response to ASX Aware Query
22/07/20PRICE SENSITIVE download Created with Sketch. 740.97KB
BOT BTX 1503 End of Phase 2 Milestone with FDA
17/07/20PRICE SENSITIVE download Created with Sketch. 160.69KB
BOT Appendix 4C - Quarterly
30/04/20PRICE SENSITIVE download Created with Sketch. 303.6KB
BOT FDA Grants BTX 1801 QIDP Designation Status
24/04/20PRICE SENSITIVE download Created with Sketch. 275.59KB
BOT Botanix Provides Update on Development Activities Amended
16/04/20PRICE SENSITIVE download Created with Sketch. 300.12KB
BOT Botanix Provides Update on Development Activities
16/04/20PRICE SENSITIVE download Created with Sketch. 243.29KB
BOT Botanix Announces Top Line BTX 1204 Atopic Dermatitis Data
25/03/20PRICE SENSITIVE download Created with Sketch. 218.13KB
BOT Trading Halt
24/03/20PRICE SENSITIVE download Created with Sketch. 215.48KB
BOT Antimicrobial Platform Update and Launch of BTX 1801 Study
13/03/20PRICE SENSITIVE download Created with Sketch. 5.77MB
BOT Half Yearly Report and Accounts
28/02/20PRICE SENSITIVE download Created with Sketch. 925.03KB
BOT Appendix 4C - Quarterly
31/01/20PRICE SENSITIVE download Created with Sketch. 380KB
BOT Botanix Initiates BTX 1702 Rosacea Study
09/12/19PRICE SENSITIVE download Created with Sketch. 160.86KB
(20min delay)
Last
40.3¢
Change
0.013(3.21%)
Mkt cap ! $725.6M
Open High Low Value Volume
39.5¢ 40.5¢ 39.5¢ $1.112M 2.795M

Buyers (Bids)

No. Vol. Price($)
13 284597 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
40.5¢ 118984 12
View Market Depth
Last trade - 11.04am 02/10/2024 (20 minute delay) ?
Last
40.3¢
  Change
0.013 ( 3.15 %)
Open High Low Volume
39.5¢ 40.3¢ 39.5¢ 427894
Last updated 11.20am 02/10/2024 ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.